Natural products and body weight control

North American Journal of Medical Sciences

Volumn 3, Issue 1, 2011, Pages 13-19

  Lee, Jay ^a   Li, Yanmei ^a   Li, Chunhua ^a   Li, Duo ^b  

^a Beijing Gingko Group ^*  (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Astaxanthin; Capsaicin; Catechins; Conjugated linoleic acid; Cyaniding 3 glucoside; Fucoxanthin; Glabridin; Natural products; Obesity; Soy isoflavone

Indexed keywords

ASTAXANTHIN; CAPSAICIN; CATECHIN; CONJUGATED LINOLEIC ACID; CYNIDIN 3 GLUCOSIDE; FUCOXANTHIN; GLABRIDIN; MESSENGER RNA; NATURAL PRODUCT; SOY ISOFLAVONE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; VANILLOID RECEPTOR 1;

ADIPOCYTE; ANTIOBESITY ACTIVITY; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; ENERGY EXPENDITURE; HUMAN; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; TEA; TREATMENT DURATION; WEIGHT CONTROL; WEIGHT REDUCTION;

EID: 79952586338     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.313     Document Type: Review

References (53)

1. World Health Organization. Obesity and overweight. September 2006 (Accessed July 24, 2010, at http://www.who.int/mediacentre/factsheets/fs311/en
2. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007; 335 (7631): 1194-1199.
3. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007; 369(9555):71-77.
4. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004; 500(1-3):177-185.
5. Yang TT, Koo MW. Hypocholesterolemic effects of Chinese tea. Pharmacol Res. 1997;35(6):505-512.
6. Ashida H, Furuyashiki T, Nagayasu H, et al. Anti-obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. Biofactors 2004; 22: 135-140.
7. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, et al. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol Behav 2008; 93:486-491.
8. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav 2006; 87: 185-191.
9. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 2004; 91(3):431-437.
10. Klaus S, Pültz S, Thöne-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes 2005; 29(6): 615-623.
11. Juhel C, Armand M, Pafumi Y, Rosier C, Vandermander J, Lairon D. Green tea extract (AR25t) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 2000; 11(1): 45-51.
12. Furuyashiki T, Nagayasu H, Aoki Y, et al. Tea Catechin Suppresses Adipocyte Differentiation Accompanied by Down-regulation of PPAR?2 and C/EBPa in 3T3-L1 Cells. Biosci Biotechnol Biochem 2004; 68(11):2353-2359.
13. Lin J, Della-Fera MA, Baile CA. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res 2005;13(6):82-90.
14. Wu BT, Hung PF, Chen HC, Huang RN, Chang HH, Kao YH. The Apoptotic Effect of Green Tea (-)-Epigallocatechin Gallate on 3T3-L1 Preadipocytes Depends on the Cdk2 Pathway. J Agric Food Chem 2005;53(14):5695-5701.
15. Donnerer J, Amann R, Schuligoi R, Lembeck F. Absorption and metabolism of capsaicinoids following intragastric administration in rats. Naunyn Schmiedebergs Arch Pharmacol 1990; 342(3): 357-361.
16. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43(2):143-201.
17. Gram DX, Hansen AJ, Wilken M, et al. Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol 2005;153(6):963-969.
18. FW. Capsaicin-sensitive intestinal mucosal afferent mechanism and body fat distribution. Life Sci 2008; 83(1-2):1-5.
19. Cui J, Himms-Hagen J. Long-term decrease in body fat and in brown adipose tissue in capsaicin-desensitized rats. Am J Physiol 1992;262(4 Pt 2): R568-573.
20. Engeli S, Schling P, Gorzelniak K, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003;35(6):807-825.
21. Sasahara I, Furuhata Y, Iwasaki Y, et al. Assessment of the biological similarity of three capsaicin analogs (Capsinoids) found in non-pungent chili pepper (CH-19 Sweet) fruits. Biosci Biotechnol Biochem 2010; 74(2):274-278.
22. Zhang LL, Liu DY, Ma LQ, et al. Activation of Transient Receptor Potential Vanilloid Type-1 Channel Prevents Adipogenesis and Obesity. Circ Res 2007;100:934-936.
23. Motter AL, Ahern GP.TRPV1-null mice are protected from diet-induced obesity. FEBS Lett 2008; 582: 2257-2262.
24. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun 2005; 332(2):392-397.
25. Maeda H, Hosokawa M, Sashima T, Miyashita K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J Agric Food Chem 2007;55 (19):7701-7706.
26. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J Oleo Sci 2007; 56(12): 615-621.
27. Woo MN, Jeon SM, Shin YC, Lee MK, Kang MA, Choi MS. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol Nutr Food Res 2009;53(12):1603-1611.
28. Hosokawa M, Miyashita T, Nishikawa S, et al. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-A(y) mice. Arch Biochem Biophys 2010 May 31 [Epub ahead of print]
29. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002;76:1191-1201.
30. Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci 2007; 4:72-82.
31. Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997;82(2):414-417.
32. Mori M, Aizawa T, Tokoro M, Miki T, Yamori Y. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women. Clin Exp Pharmacol Physiol 2004;31 Suppl 2:S39-S41.
33. Cheng SY, Shaw NS, Tsai KS, Chen CY. The hypoglycemic effects of soy isoflavones on postmenopausal women. J Women Health (Larchmt) 2004; 13(10):1080-1086.
34. Charles C, Yuskavage J, Carlson O, et al. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009;16(2):395-400.
35. Weickert MO, Reimann M, Otto B, et al. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed 2006;5:11.
36. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997;32:53-858.
37. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 1998; 275:R667-R672.
38. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999; 34:235-241.
39. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003;44:2234-2241.
40. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000;130(12):2943-2948.
41. Larsen TM, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr 2006;83:606-612.
42. Gaullier JM, Halse J, Høye K, et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005;135(4):778-784.
43. Terpstra AH, Beynen AC, Everts H, Kocsis S, Katan MB, Zock PL. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. J Nutr 2002; 132:940-945.
44. Wendel AA, Purushotham A, Liu LF, Belury MA. Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice. Lipids. 2009; 44: 975-982.
45. Nakagawa K, Kishida H, Arai N, Nishiyama T, Mae T. Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol Pharm Bull 2004; 27: 1775-1778.
46. Aoki F, Honda S, Kishida H, et al. Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci Biotechnol Biochem 2007; 71: 206-214.
47. Tominaga Y, Mae T, Kitano M, Sakamoto Y, Ikematsu H, Nakagawa K. Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects. J Health Sci 2006;52: 672-683.
48. Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem. 2007; 71(4): 893-899.
49. Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin supplementation on exercise-induced fatigue in mice. Biol Pharm Bull 2006; 29(10):2106-2110.
50. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003; 133 (7): 2125-2130.
51. Tsuda T, Ueno Y, Aoki H, et al. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commun 2004; 316(1):149-157.
52. Tsuda T, Ueno Y, Kojo H, Yoshikawa T, Osawa T. Gene expression profile of isolated rat adipocytes treated with anthocyanins. Biochim Biophys Acta 2005; 1733(2-3):137-147.
53. Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 2006;71(8):1184-1197.s